169 related articles for article (PubMed ID: 25498393)
1. Incidence rate of fluoroquinolone-resistant gram-negative rod bacteremia among allogeneic hematopoietic cell transplantation patients during an era of levofloxacin prophylaxis.
Miles-Jay A; Butler-Wu S; Rowhani-Rahbar A; Pergam SA
Biol Blood Marrow Transplant; 2015 Mar; 21(3):539-45. PubMed ID: 25498393
[TBL] [Abstract][Full Text] [Related]
2. Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.
Seo SK; Xiao K; Huang YT; Jongwutiwes U; Chung D; Maloy M; Giralt S; Barker JN; Jakubowski AA; Papanicolaou GA
J Infect; 2014 Oct; 69(4):341-351. PubMed ID: 24931578
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yanez San Segundo L; Pabst T; Özçelik T; Klyasova G; Donnini I; Wu D; Gülbas Z; Zuckerman T; Botelho de Sousa A; Beguin Y; Xhaard A; Bachy E; Ljungman P; de la Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
Clin Infect Dis; 2017 Nov; 65(11):1819-1828. PubMed ID: 29020364
[TBL] [Abstract][Full Text] [Related]
4. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
5. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
[TBL] [Abstract][Full Text] [Related]
7. Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization.
Brigmon MM; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Clin Microbiol Infect; 2015 Sep; 21(9):843-9. PubMed ID: 26003282
[TBL] [Abstract][Full Text] [Related]
8. Role of fluoroquinolone prophylaxis in allogeneic hematopoietic cell transplantation in regions with a high prevalence of fluoroquinolone resistance.
Nair A; Kaundal S; Kasudhan KS; Chopra M; Singh C; Jandial A; Jain A; Prakash G; Khadwal A; Angrup A; Patil A; Ray P; Malhotra P; P Lad D
Blood Cell Ther; 2023 May; 6(2):61-65. PubMed ID: 37346770
[TBL] [Abstract][Full Text] [Related]
9. The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma.
Guare EG; Hale CM; Sivik J; Lehman E; Inoue Y; Rakszawski K; Songdej N; Nickolich M; Zheng H; Naik S; Claxton D; Rybka W; Hohl R; Mineishi S; Minagawa K; Paules CI
Transpl Infect Dis; 2024 Apr; 26(2):e14241. PubMed ID: 38269469
[TBL] [Abstract][Full Text] [Related]
10. Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
Satlin MJ; Chen L; Douglass C; Hovan M; Davidson E; Soave R; La Spina M; Gomez-Arteaga A; van Besien K; Mayer S; Phillips A; Hsu JM; Malherbe R; Small CB; Jenkins SG; Westblade LF; Kreiswirth BN; Walsh TJ
Clin Infect Dis; 2021 Oct; 73(7):1257-1265. PubMed ID: 33956965
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
Ogura S; Kimura M; Takagi S; Mitsuki T; Yuasa M; Kageyama K; Kaji D; Nishida A; Taya Y; Ishiwata K; Yamamoto H; Asano-Mori Y; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):941-948. PubMed ID: 33185742
[TBL] [Abstract][Full Text] [Related]
12. Impact of fluoroquinolone administration and gut mucosal colonization on the risk of pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation.
Akhmedov M; Klyasova G; Kuzmina L; Fedorova A; Drokov M; Parovichnikova E
Leuk Lymphoma; 2023 Jun; 64(6):1102-1111. PubMed ID: 37086466
[TBL] [Abstract][Full Text] [Related]
13. [Gram-negative bacteremia in neutropenic patients with hematologic disorders. Experiences with prophylactic use of fluoroquinolones].
Sinkó J; Cser V; Konkoly Thege M; Masszi T
Orv Hetil; 2011 Jul; 152(27):1063-7. PubMed ID: 21676672
[TBL] [Abstract][Full Text] [Related]
14. Increasing incidence of gram-negative rod bacteremia in a newborn intensive care unit.
Shah SS; Ehrenkranz RA; Gallagher PG
Pediatr Infect Dis J; 1999 Jul; 18(7):591-5. PubMed ID: 10440433
[TBL] [Abstract][Full Text] [Related]
15. Gram-negative Bacteremia in Children With Hematologic Malignancies and Following Hematopoietic Stem Cell Transplantation: Epidemiology, Resistance, and Outcome.
Vinker-Shuster M; Stepensky P; Temper V; Shayovitz V; Masarwa R; Averbuch D
J Pediatr Hematol Oncol; 2019 Nov; 41(8):e493-e498. PubMed ID: 31318820
[TBL] [Abstract][Full Text] [Related]
16. Proposal of a clinical score to stratify the risk of multidrug-resistant gram-negative rods bacteremia in cancer patients.
Carena AA; Laborde A; Roccia-Rossi I; Palacios CJ; Jordán R; Valledor A; Nenna A; Costantini P; Dictar M; Herrera F;
Braz J Infect Dis; 2020; 24(1):34-43. PubMed ID: 31851901
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB.
Clerici D; Galli L; Greco R; Lugli AP; Erbella F; Ripa M; Tassan Din C; Nitti R; Giglio F; Mastaglio S; Lorentino F; Xue E; Farina F; Liberatore C; Poli A; Carletti S; Lupo Stanghellini MT; Carrabba MG; Assanelli AA; Ruggeri A; Bernardi M; Corti C; Peccatori J; Mancini N; Scarpellini P; Ciceri F; Castagna A; Oltolini C
Blood Adv; 2023 May; 7(9):1621-1634. PubMed ID: 36409602
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey.
Girmenia C; Bertaina A; Piciocchi A; Perruccio K; Algarotti A; Busca A; Cattaneo C; Raiola AM; Guidi S; Iori AP; Candoni A; Irrera G; Milone G; Marcacci G; Scimè R; Musso M; Cudillo L; Sica S; Castagna L; Corradini P; Marchesi F; Pastore D; Alessandrino EP; Annaloro C; Ciceri F; Santarone S; Nassi L; Farina C; Viscoli C; Rossolini GM; Bonifazi F; Rambaldi A;
Clin Infect Dis; 2017 Nov; 65(11):1884-1896. PubMed ID: 29020286
[TBL] [Abstract][Full Text] [Related]
19. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
Mikulska M; Del Bono V; Raiola AM; Bruno B; Gualandi F; Occhini D; di Grazia C; Frassoni F; Bacigalupo A; Viscoli C
Biol Blood Marrow Transplant; 2009 Jan; 15(1):47-53. PubMed ID: 19135942
[TBL] [Abstract][Full Text] [Related]
20. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]